Strong growth in autoimmune drug target discovery in 2022

Two targets were chosen for their novelty – transcription factor CEBPB and transport protein MX2, both reported to be associated to Lupus in 2022.

Written by
Anna Tzani
  • Categories
  • Target Selection
Receive the latest newsletter directly to your inbox

What kind of targets are researchers focused on?

More on Target Selection